CartiHeal Receives FDA “Breakthrough Device Designation” for the novel Agili-C Implant
Breakthrough Designation Allows Expedited Review KFAR SABA, Israel, Oct. 12, 2020 /PRNewswire/ -- CartiHeal, developer of Agili-C™, a proprietary implant for the treatment of cartilage lesions in arthritic and non-arthritic joints, announced today that...